ARTICLE | Distillery Therapeutics
Cancer
November 26, 2018 8:04 PM UTC
Cell culture and mouse studies suggest inhibiting phosphorylation of BRAF at S729 could enhance the efficacy of BRAF inhibitors for BRAF V600E-mutant melanoma. In two human BRAF V600E-mutant melanoma ...
BCIQ Company Profiles
BCIQ Target Profiles